NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone
nRx Pharmicals公布了其 NRX-101 Vs. 2b/3阶段试验的结果后,该公司股价走低卢拉西酮
NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone
nRx Pharmicals公布了其 NRX-101 Vs. 2b/3阶段试验的结果后,该公司股价走低卢拉西酮
使用浏览器的分享功能,分享给你的好友吧